Treatment Patterns, Adherence, and Persistence in ADHD: A Canadian Perspective

References

• . Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry. 2003;2(2):104–113
   PubMedGoogle Scholar
• . Kessler RC, Adler L, Ames M, . The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med. 2005;47(6):565–572
   PubMed Web of Science ®Google Scholar
• . Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005;366(9481):237–248
   PubMed Web of Science ®Google Scholar
• . Langley K, Fowler T, Ford T, . Adolescent clinical outcomes for young people with attention-deficit hyperactivity disorder. Br J Psychiatry. 2010;196(3):235–240
   PubMed Web of Science ®Google Scholar
• . Kessler RC, Adler L, Barkley R, . The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716–723
   PubMed Web of Science ®Google Scholar
• . Barkley RA. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood. Postgrad Med. 2008;120(3):48–59
   PubMed Web of Science ®Google Scholar
• . Adler L, Cohen J. Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004;27(2): 187–201
   PubMed Web of Science ®Google Scholar
• . Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948
   PubMed Web of Science ®Google Scholar
• . Froehlich TE, Lanphear BP, Epstein JN, Barbaresi WJ, Katusic SK, Kahn RS. Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children. Arch Pediatr Adolesc Med. 2007;161(9):857–864
   PubMed Web of Science ®Google Scholar
• . Hodgkins P, Sasané R, Meijer WM. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patter ns in the Netherlands. Clin Ther. 2011;33(2): 188–203
   PubMed Web of Science ®Google Scholar
• . Winterstein AG, Gerhard T, Shuster J, . Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database. Ann Pharmacother. 2008;42(1): 24–31
   PubMedGoogle Scholar
• . Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Ambul Pediatr. 2007;7( 1 suppl):121–131
   PubMedGoogle Scholar
• . Hodgkins P, Montejano L, Sasane R, Huse D. Cost of illness and comorbidities in adults diagnosed with attention-deficit/hyperactivity disorder: a retrospective analysis. Prim Care Companion CNS Disord. 2011;13(2):e1–e12
   Google Scholar
• . Birnbaum HG, Kessler RC, Lowe SW, . Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000. Curr Med Res Opin. 2005; 21(2):195–206
   PubMed Web of Science ®Google Scholar
• . Laucht M, Skowronek MH, Becker K, . Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry. 2007;64(5): 585–590
   PubMedGoogle Scholar
• . Indredavik MS, Vik T, Heyerdahl S, Kulseng S, Fayers P, Brubakk AM. Psychiatric symptoms and disorders in adolescents with low birth weight. Arch Dis Child Fetal Neonatal Ed. 2004;89(5):F445–F450
   PubMed Web of Science ®Google Scholar
• . Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006;114(12): 1904–1909
   PubMed Web of Science ®Google Scholar
• . Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61(12):1361–1369
   PubMed Web of Science ®Google Scholar
• . Emond V, Joyal C, Poissant H. Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD) [in French]. Encephale. 2009;35(2):107–114
   PubMed Web of Science ®Google Scholar
• . Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57(11):1336–1346
   PubMed Web of Science ®Google Scholar
• . Canadian Attention deficit Hyperactivity Disorder Resource Alliance (CADDRA). Canadian ADHD Practice Guidelines. 3rd ed. Toronto, ON; CADDRA, 2011
   Google Scholar
• . Easton N, Steward C, Marshall F, Fone K, Marsden C. Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain. Neuropharmacology. 2007;52(2):
   Google Scholar
• . Heal DJ, Smith SL, Kulkarni RS, Rowley HL. New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD. Pharmacol Biochem Behav. 2008;90(2):184–197
   PubMedGoogle Scholar
• . Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem. 1997;68(5):2032–2037
   PubMed Web of Science ®Google Scholar
• . American Academy of Pediatrics Subcommittee on Attention-deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical Practice Guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4): 1033–1044
   PubMed Web of Science ®Google Scholar
• . Asherson P. Clinical assessment and treatment of attention deficit hyperactivity disorder in adults. Expert Rev Neurother. 2005;5(4): 525–539
   PubMedGoogle Scholar
• . Banaschewski T, Coghill D, Santosh P, . Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. Eur Child Adolesc Psychiatry. 2006;15(8): 476–495
   PubMed Web of Science ®Google Scholar
• . Hammerness P, Surman C, Miller K. Update on adult attention-deficit/hyperactivity disorder. Curr Neurol Neurosci Rep. 2008;8(6): 484–489
   PubMedGoogle Scholar
• . Zuvekas SH, Vitiello B, Norquist GS. Recent trends in stimulant medication use among U.S. children. Am J Psychiatry. 2006;163(4): 579–585
   PubMed Web of Science ®Google Scholar
• . Pliszka S; AACAP Work Group in Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921
   PubMed Web of Science ®Google Scholar
• . Spencer T, Biederman J, Wilens T, . A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(5):456–463
   PubMed Web of Science ®Google Scholar
• . Kemner JE, Starr HL, Ciccone PE, Hooper–Wood CG, Crockett RS. Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. Adv Ther. 2005;22(5):498–512
   PubMedGoogle Scholar
• . Hosenbocus S, Chahal R. A review of long-acting medications for ADHD in Canada. J Can Acad Child Adolesc Psychiatry. 2009;18(4): 331–339
   PubMedGoogle Scholar
• . Strattera (atomoxetine hydrochloride). Physicians' Desk Reference. Oradell, NJ: PDR Network; 2011
   Google Scholar
• . Guanfacine hydrochloride. Physicians' Desk Reference. Oradell, NJ: PDR Network; 2011
   Google Scholar
• . Sallee FR, McGough J, Wigal T, Donahue J, Lyne A, Biederman J. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;48(2):155–165
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry. 2010;71(6):754–763
   PubMed Web of Science ®Google Scholar
• . World Health Organization. Adherence to long-term therapies: evidence for action. http://www.who.int/chp/knowledge/publications/adherence_report/en/. Published 2003. Accessed January 3, 2012
   Google Scholar
• . Gau SS, Chen SJ, Chou WJ, . National survey of adherence, efficacy, and side effects of methylphenidate in children with attention-deficit/hyperactivity disorder in Taiwan. J Clin Psychiatry. 2008; 69(1):131–140
   PubMed Web of Science ®Google Scholar
• . Faraone SV, Wilens T. Does stimulant treatment lead to substance use disorders? J Clin Psychiatry. 2003;64( suppl 11):9–13
   PubMed Web of Science ®Google Scholar
• . Safren SA, Duran P, Yovel I, Perlman CA, Sprich S. Medication adherence in psychopharmacologically treated adults with ADHD. J Atten Disord. 2007;10(3):257–260
   PubMedGoogle Scholar
• . Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin. 2010;26(4):977–989
   PubMed Web of Science ®Google Scholar
• . Perwien A, Hall J, Swensen A, Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. J Manag Care Pharm. 2004;10(2):122–129
   PubMedGoogle Scholar
• . Régie de l'assurance maladie Québec. Studies and statistics. http://www.ramq.gouv.qc.ca/en/statistiques/index.shtml. Accessed September 16, 2011
   Google Scholar
• . Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45(2):197–203
   PubMed Web of Science ®Google Scholar
• . Sasane R, Hodgkins P, Meijer W. Treatment stabilization in children and adolescents with attention-deficit/hyperactivity disorder: data from the Netherlands. Curr Med Res Opin. 2010;26(11):2565–2574
   PubMed Web of Science ®Google Scholar
• . Stein MT, Shafer MA, Elliott GR, Levine S. An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr. 1999;20(2):106–110
   PubMedGoogle Scholar
• . Garland EJ. Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats. J Psychopharmacol. 1998;12(4):385–395
   PubMedGoogle Scholar
• . Charach A, Volpe T, Boydell KM, Gearing RE. A theoretical approach to medication adherence for children and youth with psychiatric disorders. Harv Rev Psychiatry. 2008;16(2):126–135
   PubMed Web of Science ®Google Scholar
• . Cromer BA, Tarnowski KJ. Noncompliance in adolescents: a review. J Dev Behav Pediatr. 1989;10(4):207–215
   PubMedGoogle Scholar
• . Faraone SV, Biederman J, Zimmerman B. An analysis of patient adherence to treatment during a 1-year, open-label study of OROS methylphenidate in children with ADHD. J Atten Disord. 2007;11(2): 157–166
   PubMedGoogle Scholar
• . Olfson M, Marcus S, Wan G. Stimulant dosing for children with ADHD: a medical claims analysis. J Am Acad Child Adolesc Psychiatry. 2009;48(1):51–59
   PubMedGoogle Scholar
• . Chou WJ, Chou MC, Tzang RF, . Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Psychiatry Clin NeuroSci. 2009;63(2):167–175
   PubMed Web of Science ®Google Scholar
• . Kemner JE, Lage MJ. Effect of methylphenidate formulation on treatment patterns and use of emergency room services. Am J Health Syst Pharm. 2006;63(4):317–322
   PubMedGoogle Scholar
• . Steele M, Weiss M, Swanson J, Wang J, Prinzo RS, Binder CE. A randomized, controlled effectiveness trial of oros-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder. Can J Clin Pharmacol. 2006; 13(1):e50–e62
   PubMedGoogle Scholar
• . Volk HE, Newmann RJ, Todd RD. A systematic evaluation of ADHD and comorbid psychopathology in a population-based twin sample. J Am Acad Child Adolesc Psychiatry. 2005;44(8):768–775
   PubMedGoogle Scholar